Global epidemiology of HIV among women and girls who use or inject drugs: Current knowledge and limitations of existing data

Journal of Acquired Immune Deficiency Syndromes

Volumn 69, Issue , 2015, Pages S100-S109

  Larney, Sarah ^a,b   Mathers, Bradley M ^c   Poteat, Tonia ^d   Kamarulzaman, Adeeba ^e   Degenhardt, Louisa ^a,f  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF MALAYA   (Malaysia)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Girls; HIV; People who inject drugs; People who use drugs; Prevalence; Women

Indexed keywords

ARTICLE; ETHNIC GROUP; FEMALE; GIRL; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HEALTH SERVICE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTIMACY; INTRAVENOUS DRUG ABUSE; META ANALYSIS (TOPIC); PARTNER VIOLENCE; PERSONAL EXPERIENCE; PRIORITY JOURNAL; RACE; SEXUAL MINORITY; SOCIAL DISCRIMINATION; SOCIAL STIGMA; SUBSTANCE ABUSE; SYSTEMATIC REVIEW (TOPIC); TRANSGENDER; UNSAFE SEX; VULNERABLE POPULATION; WOMEN WHO HAVE SEX WITH WOMEN; COMPLICATION; HEALTH; HIV INFECTIONS; PREVALENCE; RISK FACTOR;

FEMALE; GLOBAL HEALTH; HIV INFECTIONS; HUMANS; PREVALENCE; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84938502317     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000623     Document Type: Article

References (90)

1. UNAIDS. The Gap Report. UNAIDS; 2014. Available at: http://www.unaids.org/sites/default/files/media-asset/UNAIDS-Gap-report-en.pdf. Accessed December 9, 2014.
2. Strathdee SA, Stockman JK. Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions. Curr HIV/AIDS Rep. 2010;7:99-106.
3. Degenhardt L, Whiteford H, Ferrari A, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382:1564-1574.
4. Degenhardt L, Baxter AJ, Lee YY, et al. The global epidemiology and burden of psychostimulant dependence: findings from the Global Burden of Disease Study 2010. Drug Alcohol Depend. 2014;137:36-47.
5. Degenhardt L, Charlson F, Mathers B, et al. The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study. Addiction. 2014;109:1320-1333.
6. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224-2260.
7. Degenhardt L, Bucello C, Mathers BM, et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction. 2011;106:32-51.
8. Lejcková P, Mravcík V. Mortality of hospitalized drug users in the Czech republic. J Drug Issues. 2007;37:103-118.
9. Mathers B, Degenhardt L, Bucello C, et al. Mortality among people who inject drugs: a meta-analytic review. Bull World Health Organ. 2013;91:102-123.
10. Mathers BM, Degenhardt L. Examining non-AIDS mortality among people who inject drugs. AIDS. 2014;28:S435-S444.
11. AIDSInfo. UNAIDS, 2014. Available at: http://www.unaids.org/en/dataanalysis/datatools/aidsinfo. Accessed December 20, 2014.
12. Des Jarlais DC, Feelemyer JP, Modi SN, et al. Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas. Drug Alcohol Depend. 2012;124:95-107.
13. Jolley E, Rhodes T, Platt L, et al. HIV among people who inject drugs in Central and Eastern Europe and Central Asia. BMJ Open. 2012;2:e001465.
14. Des Jarlais DC, Arasteh K, McKnight C, et al. HSV-2 infection as a cause of female/male and racial/ethnic disparities in HIV infection. PLoS One. 2013;8:e66874.
15. Zhuang X, Wang Y, Chow EPF, et al. Risk factors associated with HIV/HCV infection among entrants in methadone maintenance treatment clinics in China: a systematic review and meta-analysis. Drug Alcohol Depend. 2012;126:286-295.
16. Broz D, Wejnert C, Pham HT, et al. HIV infection and risk, prevention, and testing behaviors among injecting drug users - National HIV Behavioral Surveillance System, 20 U.S. Cities, 2009. MMWR Surveill Summ. 2014;63:1-56.
17. Lansky A, Finlayson T, Johnson C, et al. Estimating the number of persons who inject drugs in the United States by meta-analysis to calculate national rates of HIV and hepatitis C virus infections. PLoS One. 2014;9:e97596.
18. Polk S, Ellen JM, Fichtenberg C, et al. HIV prevalence overall and among high-HIV-risk behaviorally defined subgroups among heterosexuals at community-based venues in a mid-atlantic, US city. J Urban Health. 2013;90:747-757.
19. Magnus M, Kuo I, Phillips II G, et al. Differing HIV risks and prevention needs among men and women injection drug users (IDU) in the District of Columbia. J Urban Health. 2013;90:157-166.
20. Deiss RG, Lozada RM, Burgos JL, et al. HIV prevalence and sexual risk behaviour among non-injection drug users in Tijuana, Mexico. Glob Public Health. 2012;7:175-183.
21. Des Jarlais DC, Arasteh K, Perlis T, et al. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS. 2007;21:231-235.
22. Removille N, Origer A, Couffignal S, et al. A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations. BMC Public Health. 2011;11:351.
23. Neagius A, Miller M, Gyarmathy VA, et al. HIV heterosexual sexual risk from injecting drug users among HIV-seronegative noninjecting heroin users. Subst Use Misuse. 2011;46:208-217.
24. Barrio G, De La Fuente L, Toro C, et al. Prevalence of HIV infection among young adult injecting and non-injecting heroin users in Spain in the era of harm reduction programmes: gender differences and other related factors. Epidemiol Infect. 2007;135: 592-603.
25. Ritter A, Matthew-Simmons F, Carragher N. Prevalence of and Interventions for Mental Health and Alcohol and Other Drug Problems Amongst the Gay, Lesbian, Bisexual and Transgender Community: A Review of the Literature. Sydney, Australia: Drug Policy Model Program, University of NSW; 2012.
26. Fethers K, Marks C, Mindel A, et al. Sexually transmitted infections and risk behaviours in women who have sex with women. Sex Transm Infect. 2000;76:345-349.
27. Hillier L, De Visser R, Kavanagh AM, et al. The association between licit and illicit drug use and sexuality in young Australian women. Med J Aust. 2003;179:326-327.
28. King M, Semlyen J, Tai SS, et al. A systematic review of mental disorder, suicide, and deliberate self harm in lesbian, gay and bisexual people. BMC Psychiatry. 2008;8:70.
29. Kral AH, Lorvick J, Bluthenthal RN, et al. HIV risk profile of drug-using women who have sex with women in 19 United States cities. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16:211-217.
30. Ompad DC, Friedman SR, Hwahng SJ, et al. HIV risk behaviors among young drug using women who have sex with women (WSWs) in New York city. Subst Use Misuse. 2011;46:274-284.
31. Friedman SR, Ompad DC, Maslow C, et al. HIV prevalence, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women. Am J Public Health. 2003; 93:902-906.
32. Young RM, Friedman SR, Case P, et al. Women injection drug users who have sex with women exhibit increased HIV infection and risk behaviors. J Drug Issues. 2000;30:499-524.
33. Flentje A, Bacca CL, Cochran BN. Missing data in substance abuse research? Researchers' reporting practices of sexual orientation and gender identity. Drug Alcohol Depend. 2014;147:280-284.
34. Gomez-Gil E, Trilla A, Salamero M, et al. Sociodemographic, clinical, and psychiatric characteristics of transsexuals from Spain. Arch Sex Behav. 2009;38:378-392.
35. Reisner SL, White JM, Bradford JB, et al. Transgender health disparities: comparing full cohort and nested matched-pair study designs in a community health center. LGBT Health. 2014;1:177-184.
36. Dias S, Gama A, Fuertes R, et al. Risk-taking behaviours and HIV infection among sex workers in Portugal: results from a cross-sectional survey. Sex Transm Infect. 2014; doi: 10.1136/sextrans-2014-051697.
37. Nemoto T, Operario D, Keatley J, et al. Promoting health for transgender women: Transgender Resources and Neighborhood Space (TRANS) program in San Francisco. Am J Public Health. 2005;95:382-384.
38. ∗female youth ages 16-24 years in the San Francisco Bay Area. Drug Alcohol Depend. Available at: http://dx.doi.org/10.1016/j.drugalcdep.2014.11.023. 2015;147:160-166.
39. Bokhari A, Nizamani NM, Jackson DJ, et al. HIV risk in Karachi and Lahore, Pakistan: an emerging epidemic in injecting and commercial sex networks. Int J STD AIDS. 2007;18:486-492.
40. Hounsfield VL, Freedman E, McNulty A, et al. Transgender people attending a Sydney sexual health service over a 16-year period. Sex Health. 2007;4:189-193.
41. Herbst JH, Jacobs ED, Finlayson TJ, et al. Estimating HIV prevalence and risk behaviors of transgender persons in the United States: a systematic review. AIDS Behav. 2008;12:1-17.
42. Flentje A, Heck NC, Sorensen JL. Characteristics of transgender individuals entering substance abuse treatment. Addict Behav. 2014;39: 969-975.
43. Sevelius JM, Reznick OG, Hart SL, et al. Informing interventions: the importance of contextual factors in the prediction of sexual risk behaviors among transgender women. AIDS Educ Prev. 2009;21:113-127.
44. Baral SD, Poteat T, Strömdahl S, et al. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13:214-222.
45. Emmanuel F, Salim M, Akhtar N, et al. Second-generation surveillance for HIV/AIDS in Pakistan: results from the 4th round of Integrated Behavior and Biological Survey 2011-2012. Sex Transm Infect. 2013;89 (suppl 3):iii23-iii28.
46. Guy R, Mustikawati DE, Wijaksono DB, et al. Voluntary counselling and testing sites as a source of sentinel information on HIV prevalence in a concentrated epidemic: a pilot project from Indonesia. Int J STD AIDS. 2011;22:505-511.
47. Bowers JR, Branson CM, Fletcher JB, et al. Predictors of HIV sexual risk behavior among men who have sex with men, men who have sex with men and women, and transgender women. Int J Sex Health. 2012;24:290-302.
48. Des Jarlais DC, Bramson HA, Wong C, et al. Racial/ethnic disparities in HIV infection among people who inject drugs: an international systematic review and meta-analysis. Addiction. 2012;107:2087-2095.
49. Des Jarlais DC, Arasteh K, Hagan H, et al. Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs. Am J Public Health. 2009; 99(SUPPL. 2):S445-S451.
50. Wood E, Montaner JS, Li K, et al. Burden of HIV infection among aboriginal injection drug users in Vancouver, British Columbia. Am J Public Health. 2008;98:515-519.
51. Busza J, Douthwaite M, Bani R, et al. Injecting behaviour and service use among young injectors in Albania, Moldova, Romania and Serbia. Int J Drug Policy. 2013;24:423-431.
52. Busza JR, Balakireva OM, Teltschik A, et al. Street-based adolescents at high risk of HIV in Ukraine. J Epidemiol Community Health. 2011;65: 1166-1170.
53. Horyniak D, Dietze P, Degenhardt L, et al. The relationship between age and risky injecting behaviours among a sample of Australian people who inject drugs. Drug Alcohol Depend. 2013;132:541-546.
54. Robbins CL, Zapata L, Kissin DM, et al. Multicity HIV seroprevalence in street youth, Ukraine. Int J STD AIDS. 2010;21:489-496.
55. Kissin DM, Zapata L, Yorick R, et al. HIV seroprevalence in street youth, St Petersburg, Russia. AIDS. 2007;21:2333-2340.
56. Atkinson J, McCurdy S, Williams M, et al. HIV risk behaviours, perceived severity of drug use problems, and prior treatment experience in a sample of young heroin injectors in Dar es Salaam, Tanzania. Afr J Drug Alcohol Stud. 2011;10:1-9.
57. Otiashvili D, Kirtadze I, O'Grady KE, et al. Access to treatment for substance-using women in the Republic of Georgia: socio-cultural and structural barriers. Int J Drug Policy. 2013;24:566-572.
58. Kirtadze I, Otiashvili D, O'Grady KE, et al. Twice stigmatized: provider's perspectives on drug-using women in the Republic of Georgia. J Psychoactive Drugs. 2013;45:1-9.
59. El-Bassel N, Wechsberg WM, Shaw SA. Dual HIV risk and vulnerabilities among women who use or inject drugs: no single prevention strategy is the answer. Curr Opin HIV AIDS. 2012;7:326-331.
60. Lambdin BH, Bruce RD, Chang O, et al. Identifying programmatic gaps: inequities in harm reduction service utilization among male and female drug users in Dar es Salaam, Tanzania. PLoS One. 2013;8:e67062.
61. Strathdee S, Sherman SG. The role of sexual transmission of HIV infection among injection and non-injection drug users. J Urban Health. 2003;80(SUPPL. 3):iii7-iii14.
62. Vickerman P, Martin NK, Roy A, et al. Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission? Drug Alcohol Depend. 2013; 132:172-181.
63. Strathdee SA, Galai N, Safaiean M, et al. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch Intern Med. 2001;161:1281-1288.
64. Corsi KF, Dvoryak S, Garver-Apgar C, et al. Gender differences between predictors of HIV status among PWID in Ukraine. Drug Alcohol Depend. 2014;138:103-108.
65. Boily MC, Baggaley RF, Wang L, et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis. 2009;9:118-129.
66. Vasquez C, Lioznov D, Nikolaenko S, et al. Gender disparities in HIV risk behavior and access to health care in St. Petersburg, Russia. AIDS Patient Care and STDS. 2013;27:304-310.
67. Lau JTF, Tsui HY, Zhang Y, et al. Comparing HIV-related syringe-sharing behaviors among female IDU engaging versus not engaging in commercial sex. Drug Alcohol Depend. 2008;97:54-63.
68. Croxford S, Platt L, Hope VD, et al. Sex work amongst people who inject drugs in England, Wales and Northern Ireland: findings from a National Survey of Health Harms and Behaviours. Int J Drug Policy. 2014;26:429-433.
69. Tang Z, Zhang C, Li X, et al. HIV risk among female sex workers with different patterns of drug use behaviors in Southwest China: a cross-sectional study. AIDS Care. 2014;27:293-300.
70. Platt L, Rhodes T, Lowndes CM, et al. Impact of gender and sex work on sexual and injecting risk behaviors and their association with HIV positivity among injecting drug users in an HIV epidemic in Togliatti City, Russian Federation. Sex Transm Dis. 2005;32:605-612.
71. Spittal PM, Bruneau J, Craib KJP, et al. Surviving the sex trade: a comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs. AIDS Care. 2003;15:187-195.
72. Tyndall MW, Patrick D, Spittal P, et al. Risky sexual behaviours among injection drugs users with high HIV prevalence: implications for STD control. Sex Transm Infect. 2002;78(SUPPL. 1):i170-i175.
73. Strathdee SA, West BS, Reed E, et al. Substance use and HIV among female sex workers and female prisoners: risk environments and implications for prevention, treatment, and policies. J Acquir Immune Defic Syndr. 2015;69(SUPPL. 2):S110-S117.
74. Poteat T, Wirtz AL, Radix A, et al. HIV risk and preventive interventions in transgender women sex workers. Lancet. 2015;385:274-286.
75. Nemoto T, Bödeker B, Iwamoto M, et al. Practices of receptive and insertive anal sex among transgender women in relation to partner types, sociocultural factors, and background variables. AIDS Care. 2014;26:434-440.
76. Simmons J, Rajan S, McMahon JM. Retrospective accounts of injection initiation in intimate partnerships. Int J Drug Policy. 2012; 23:303-311.
77. Wood E, Spittal PM, Kerr T, et al. Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention. Can J Public Health. 2003;94:355-359.
78. Young AM, Larian N, Havens JR. Gender differences in circumstances surrounding first injection experience of rural injection drug users in the United States. Drug Alcohol Depend. 2014;134:401-405.
79. Bryant J, Brener L, Hull P, et al. Needle sharing in regular sexual relationships: an examination of serodiscordance, drug using practices, and the gendered character of injecting. Drug Alcohol Depend. 2010;107:182-187.
80. Goldsamt LA, Harocopos A, Kobrak P, et al. Circumstances, pedagogy and rationales for injection initiation among new drug injectors. J Community Health. 2010;35:258-267.
81. Roberts A, Mathers B, Degenhardt L; on behalf of the Reference Group to the United Nations on HIV and Injecting Drug Use. Women Who Inject Drugs: A Review of their Risks, Experiences and Needs. Sydney, Australia: National Drug and Alcohol Research Centre, University of NSW; 2010.
82. El-Bassel N, Shaw SA, Dasgupta A, et al. People who inject drugs in intimate relationships: it takes two to combat HIV. Curr HIV/AIDS Rep. 2014;11:45-51.
83. Des Jarlais DC, Boltaev A, Feelemyer J, et al. Gender disparities in HIV infection among persons who inject drugs in Central Asia: a systematic review and meta-analysis. Drug Alcohol Depend. 2013;132(SUPPL. 1):S7-S12.
84. Razani N, Mohraz M, Kheirandish P, et al. HIV risk behavior among injection drug users in Tehran, Iran. Addiction. 2007;102:1472-1482.
85. El-Bassel N, Gilbert L, Witte S, et al. Intimate partner violence and HIV among drug-involved women: contexts linking these two epidemics - challenges and implications for prevention and treatment. Subst Use Misuse. 2011;46:295-306.
86. El-Bassel N, Gilbert L, Wu E, et al. Relationship between drug abuse and intimate partner violence: a longitudinal study among women receiving methadone. Am J Public Health. 2005;95:465-470.
87. El-Bassel N, Gilbert L, Wu E, et al. HIV and intimate partner violence among methadone-maintained women in New York City. Soc Sci Med. 2005;61:171-183.
88. Mumtaz GR, Weiss HA, Thomas SL, et al. HIV among people who inject drugs in the middle east and North Africa: systematic review and data Synthesis. PLoS Med. 2014;11:1-30.
89. Amin-Esmaeili M, Rahimi-Movaghar A, Haghdoost AA, et al. Evidence of HIV epidemics among non-injecting drug users in Iran: a systematic review. Addiction. 2012;107:1929-1938.
90. UNODC. Drug use in Pakistan. United Nations Office on Drugs and Crime; 2013. Available at: https://www.unodc.org/documents/pakistan//Survey-Report-Final-2013.pdf. Accessed December 12, 2014.